Literature DB >> 1649574

Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.

J Pace1, A Bertasso, N H Georgopapadakou.   

Abstract

Ro 23-9424 is a broad-spectrum antibacterial agent consisting of a cephalosporin (desacetylcefotaxime) linked through an ester bond to a fluoroquinolone (fleroxacin). Its activity against mutants of Escherichia coli TE18 resistant to both antibacterial components was examined. E. coli TE18 overproduces the AmpC beta-lactamase and is resistant to several cephalosporins, including desacetylcefotaxime (MIC, 50 micrograms/ml), although it is still susceptible to Ro 23-9424 (MIC, 0.2 microgram/ml). Thirty-five spontaneous, two-step mutants of E. coli TE18 which were resistant to fleroxacin (MIC, 50 micrograms/ml) were isolated. In the mutants, replicative DNA biosynthesis (permeabilized cells) was resistant to fleroxacin, and some mutants had porin abnormalities. However, all remained susceptible to Ro 23-9424 (MIC, 0.5 microgram/ml). Examination of beta-lactamase activity in the parent strain revealed that it hydrolyzes desacetylcefotaxime more rapidly than it does Ro 23-9424. Thus, Ro 23-9424 may be less susceptible to the gram-negative, chromosomal beta-lactamases that hydrolyze several broad-spectrum cephalosporins and may be effective in cases in which neither of its two components is active.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649574      PMCID: PMC245128          DOI: 10.1128/AAC.35.5.910

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.

Authors:  G Beskid; J Siebelist; C M McGarry; R Cleeland; K Chan; D D Keith
Journal:  Chemotherapy       Date:  1990       Impact factor: 2.544

2.  Regulation of outer membrane protein synthesis in Escherichia coli K-12: deletion of ompC affects expression of the OmpF protein.

Authors:  C A Schnaitman; G A McDonald
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

3.  Gene envY of Escherichia coli K-12 affects thermoregulation of major porin expression.

Authors:  M D Lundrigan; C F Earhart
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

4.  After pro-drug -- mutual pro-drugs.

Authors:  R Wise
Journal:  J Antimicrob Chemother       Date:  1981-05       Impact factor: 5.790

5.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

6.  Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.

Authors:  S M Harding; P E Williams; J Ayrton
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells.

Authors:  H Nikaido; E Y Rosenberg; J Foulds
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

8.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

9.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli.

Authors:  H Nikaido; E Y Rosenberg
Journal:  J Gen Physiol       Date:  1981-02       Impact factor: 4.086

View more
  4 in total

Review 1.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

2.  In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.

Authors:  K S Thomson; C C Sanders; M E Hayden
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.

Authors:  N H Georgopapadakou; A Bertasso
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.

Authors:  N H Georgopapadakou; C McCaffrey
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.